New York, Feb 12, 2026, 07:12 ET — Premarket
- Amazon Pharmacy is expanding same-day prescription delivery to additional U.S. communities
- One Medical introduced a new lab-results feature designed to streamline routine bloodwork
- Traders remain focused on AI-related spending as well as Friday’s inflation report
Shares of Amazon.com Inc slipped 1.4% in the previous session, closing at $204.08 as they head into Thursday’s trading.
The stock has become a gauge for how much investment investors are willing to accept from Big Tech—and how quickly that investment translates into cash. In this mindset, even standard product and service updates start influencing the trading action.
Healthcare has become a key battleground. Amazon is moving deeper into prescriptions and primary care, leveraging both its logistics network and the reach of One Medical.
Amazon Pharmacy plans to roll out same-day prescription delivery to roughly 4,500 U.S. cities and towns by the close of 2026, Reuters reports. This expansion will add nearly 2,000 new communities to its service area. After acquiring online pharmacy PillPack in 2018, Amazon has been experimenting with in-person pickup options using electronic kiosks at its One Medical clinics, the report notes. 1
“Patients shouldn’t have to sacrifice speed, cost, or convenience,” said John Love, vice president of Amazon Pharmacy. The company framed the rollout as a solution to access issues in some regions. 2
Amazon One Medical unveiled “Health Insights,” a beta tool that evaluates over 50 biomarkers from typical blood tests and offers tailored recommendations, created with Lifeforce. “Health Insights brings clarity to complex health data,” said Andrew Diamond, Amazon One Medical’s chief medical officer, in the announcement. 3
Another filing revealed that Amazon holds a 5.3% stake in BETA Technologies, owning 11,753,896 shares via its fully owned subsidiary, Amazon.com NV Investment Holdings. 4
All this comes as the market is still digesting Amazon’s aggressive spending plans. The company expects to pour about $200 billion into capital expenditures in 2026, up from $131 billion in 2025, mainly to boost its AI infrastructure, Reuters reported. “Amazon has to invest at these levels just to stay in the race,” said D.A. Davidson analyst Gil Luria. Another analyst cautioned that the 2026 spending might outpace operating cash flow. 5
Amazon’s cloud division is still the key focus for investors hunting operating leverage amid rising expenses. If demand stays strong but costs climb faster than revenue, the stock risks stagnating despite decent growth.
Rates remain a key focus. A robust U.S. jobs report has dampened hopes for imminent Federal Reserve rate cuts, turning the spotlight back to inflation, Reuters’ Morning Bid noted. 6
The setup works both ways. Should inflation spike and bond yields rise, high-valuation tech stocks might suffer another setback. But if inflation eases, investors could give heavy spenders like Amazon some breathing room. Still, Amazon faces a tough climb expanding its healthcare footprint against established pharmacy chains and a tightly regulated industry.
Friday brings the next major event: the U.S. Consumer Price Index for January, set to drop at 8:30 a.m. Eastern on Feb. 13, according to the Labor Department’s calendar. 7
